| Name | Tusamitamab |
|---|
| Description | Tusamitamab is an IgG1 monoclonal antibody that targets CEACAM5. Tusamitamab can be used to synthesize Tusamitamab ravtansine (SAR408701), which is a first-in-class humanized antibody-drug conjugate (ADC) that combines Tusamitamab and DM4 (a potent maytansine derivative)[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C7H16N2O |
|---|---|
| Molecular Weight | 144.21 |
| Exact Mass | 144.126263138 |